Biora Therapeutics Inc.

NASDAQ: PROG · Real-Time Price · USD
0.88
-0.04 (-3.96%)
At close: May 09, 2022, 6:00 AM

Biora Therapeutics Revenue Breakdown

Period Ending Dec 31, 2021 Dec 31, 2020
Commercial Third Party Payors Revenue 42.1M 64.43M
Commercial Third Party Payors Revenue Growth -34.66% n/a
Government Health Benefit Programs Revenue 14.09M 2.73M
Government Health Benefit Programs Revenue Growth +415.75% n/a
Patient Laboratory Distribution Partners Revenue 4.42M 7.15M
Patient Laboratory Distribution Partners Revenue Growth -38.12% n/a

Operating Expense Breakdown

Period Ending Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Selling, General, and Administrative Revenue 13.46M -4.8M 18.52M 22.71M 36.87M 32.99M 33.87M 29.92M 31.54M 29.88M 31.54M 28.95M 29.84M
Selling, General, and Administrative Revenue Growth -380.35% -125.92% -18.48% -38.39% +11.74% -2.59% +13.21% -5.16% +5.57% -5.25% +8.93% -2.99% n/a
Research and Development Revenue 6.56M 8.48M 12.23M 13.4M 11.67M 11.23M 13.04M 12.23M 11.24M 14.61M 17.08M 16.46M 15.25M
Research and Development Revenue Growth -22.71% -30.60% -8.77% +14.80% +3.98% -13.93% +6.61% +8.84% -23.06% -14.47% +3.75% +7.97% n/a